← Eichor
Study identifier: NCT06488755 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

SIM0718 Treatment of Asthma Clinical Study

Condition: Asthma; Eosinophilic  ·  Sponsor: Simcere Pharmaceutical Co., Ltd

PhasePhase 3
Planned participants418
Who can joinAll sexes, 12 Years to 75 Years
Healthy volunteersNo

About this study

Phase III clinical study of SIM0718 asthma

This description comes directly from the study's public registry record.

Talk to the study team

Yi Wang  ·  +8615805160455  ·  wangyi4@simcere.com

wei wang

Always discuss trial participation with your own doctor first.

Locations (1)

China Japan Friendship HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06488755